Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19)

[...]as the MERS-CoV progressed overtime there was more identification of asymptomatic individuals due to increased surviellance and contacts testing. Asymptomatic carriage of influenza virus was estimated to be 5.2%–35.5% [4] Based on serology, the positivity rate was 13% in asymptomatic SARS 4% in...

Full description

Saved in:
Bibliographic Details
Published in:Travel medicine and infectious disease 2020-05, Vol.35, p.101608-101608, Article 101608
Main Author: Al-Tawfiq, Jaffar A.
Format: Article
Language:English
Subjects:
Betacoronavirus
Coronavirus Infections
Coronaviruses
COVID-19
Disease transmission
Families & family life
Humans
Infections
Infectious diseases
Middle East respiratory syndrome
Middle East Respiratory Syndrome Coronavirus
Pandemics
Pathogens
Pneumonia, Viral
Respiratory diseases
SARS Virus
SARS-CoV-2
Serology
Severe acute respiratory syndrome coronavirus 2
Symptoms
Travel medicine
Viruses
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[...]as the MERS-CoV progressed overtime there was more identification of asymptomatic individuals due to increased surviellance and contacts testing. Asymptomatic carriage of influenza virus was estimated to be 5.2%–35.5% [4] Based on serology, the positivity rate was 13% in asymptomatic SARS 4% in those with mild symptoms, and 82% in those with severe disease [5]. Since the emergence of SARS-COV-2, (known initially as 2019-nCoV), in Wuhan, China, in December 2019, the number of global cases had increased significantly. [...]studies will enhance the understanding of the pathogenesis of these emerging viruses and will inform policy makers to make scientifically sound recommendations.Funding source None.CRediT authorship contribution statement Jaffar A. Al-Tawfiq: Conceptualization, Writing - original draft.Declaration of competing interest None.
ISSN:1477-8939
1873-0442
DOI:10.1016/j.tmaid.2020.101608